Development of a novel DNA-launched dengue virus type 2 infectious clone assembled in a bacterial artificial chromosome

Virus Research

Volumn 180, Issue , 2014, Pages 12-22

  Usme Ciro, Jose A ^a,d   Lopera, Jaime A ^a,c   Enjuanes, Luis ^b   Almazán, Fernando ^b   Gallego Gomez, Juan C ^a  

^a UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^b CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d Instituto Nacional de Salud   (United States)

Author keywords

Bacterial artificial chromosome; Dengue virus; Eukaryotic promoter; Flavivirus; Infectious cDNA; Reverse genetics

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; RENILLA LUCIFERIN 2 MONOOXYGENASE; VIRUS RNA;

ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; DENGUE; DENGUE VIRUS 2; GENETIC TRANSFECTION; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; REVERSE GENETICS; VERO CELL; VIRUS CULTURE; VIRUS GENOME; VIRUS MUTANT; VIRUS RECOMBINANT;

BACTERIAL ARTIFICIAL CHROMOSOME; DENGUE VIRUS; EUKARYOTIC PROMOTER; FLAVIVIRUS; INFECTIOUS CDNA; REVERSE GENETICS;

ANIMALS; CELL LINE; CHROMOSOMES, ARTIFICIAL, BACTERIAL; CYTOMEGALOVIRUS; DENGUE VIRUS; GENOMIC INSTABILITY; PROMOTER REGIONS, GENETIC; REVERSE GENETICS; VIROLOGY;

EID: 84892983175     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2013.12.001     Document Type: Article

References (62)

1. Almazan F., Gonzalez J.M., Penzes Z., Izeta A., Calvo E., Plana-Duran J., Enjuanes L. Engineering the largest RNA virus genome as an infectious bacterial artificial chromosome. Proceedings of the National Academy of Sciences of the United States of America 2000, 97(10):5516-5521.
2. Almazan F., Galan C., Enjuanes L. Engineering infectious cDNAs of coronavirus as bacterial artificial chromosomes. Methods in Molecular Biology 2008, 454:275-291.
3. Ansarah-Sobrinho C., Nelson S., Jost C.A., Whitehead S.S., Pierson T.C. Temperature-dependent production of pseudoinfectious dengue reporter virus particles by complementation. Virology 2008, 381(1):67-74.
4. Bartenschlager R., Miller S. Molecular aspects of dengue virus replication. Future Microbiology 2008, 3(2):155-165.
5. Bonaldo M.C., Mello S.M., Trindade G.F., Rangel A.A., Duarte A.S., Oliveira P.J., Freire M.S., Kubelka C.F., Galler R. Construction and characterization of recombinant flaviviruses bearing insertions between E and NS1 genes. Virology Journal 2007, 4:115.
6. Brandenburg B., Zhuang X. Virus trafficking-learning from single-virus tracking. Nature Reviews Microbiology 2007, 5(3):197-208.
7. Brunak S., Engelbrecht J., Knudsen S. Prediction of human mRNA donor and acceptor sites from the DNA sequence. Journal of Molecular Biology 1991, 220(1):49-65.
8. Chambers T.J., Hahn C.S., Galler R., Rice C.M. Flavivirus genome organization, expression, and replication. Annual Review of Microbiology 1990, 44:649-688.
9. Chao B., Tong X.K., Tang W., Li D.W., He P.L., Garcia J.M., Zeng L.M., Gao A.H., Yang L., Li J., Nan F.J., Jacobs M., Altmeyer R., Zuo J.P., Hu Y.H. Discovery and optimization of 2,4-diaminoquinazoline derivatives as a new class of potent dengue virus inhibitors. Journal of Medicinal Chemistry 2012, 55(7):3135-3143.
10. Clyde K., Barrera J., Harris E. The capsid-coding region hairpin element (cHP) is a critical determinant of dengue virus and West Nile virus RNA synthesis. Virology 2008, 379(2):314-323.
11. Crill W.D., Roehrig J.T. Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells. Journal of Virology 2001, 75(16):7769-7773.
12. de Borba L., Strottmann D.M., de Noronha L., Mason P.W., Dos Santos C.N. Synergistic interactions between the NS3(hel) and E proteins contribute to the virulence of dengue virus type 1. PLoS Neglected Tropical Diseases 2012, 6(4):e1624.
13. Falgout B., Chanock R., Lai C.J. Proper processing of dengue virus nonstructural glycoprotein NS1 requires the N-terminal hydrophobic signal sequence and the downstream nonstructural protein NS2a. Journal of Virology 1989, 63(5):1852-1860.
14. Falgout B., Pethel M., Zhang Y.M., Lai C.J. Both nonstructural proteins NS2B and NS3 are required for the proteolytic processing of dengue virus nonstructural proteins. Journal of Virology 1991, 65(5):2467-2475.
15. Filomatori C.V., Iglesias N.G., Villordo S.M., Alvarez D.E., Gamarnik A.V. RNA sequences and structures required for the recruitment and activity of the dengue virus polymerase. The Journal of Biological Chemistry 2011, 286(9):6929-6939.
16. Friebe P., Harris E. Interplay of RNA elements in the dengue virus 5' and 3' ends required for viral RNA replication. Journal of Virology 2010, 84(12):6103-6118.
17. Friebe P., Pena J., Pohl M.O., Harris E. Composition of the sequence downstream of the dengue virus 5' cyclization sequence (dCS) affects viral RNA replication. Virology 2012, 422(2):346-356.
18. Gallego-Gomez J.C., Risco C., Rodriguez D., Cabezas P., Guerra S., Carrascosa J.L., Esteban M. Differences in virus-induced cell morphology and in virus maturation between MVA and other strains (WR, Ankara, and NYCBH) of vaccinia virus in infected human cells. Journal of Virology 2003, 77(19):10606-10622.
19. Grant D., Tan G.K., Qing M., Ng J.K., Yip A., Zou G., Xie X., Yuan Z., Schreiber M.J., Schul W., Shi P.Y., Alonso S. A single amino acid in nonstructural protein NS4B confers virulence to dengue virus in AG129 mice through enhancement of viral RNA synthesis. Journal of Virology 2011, 85(15):7775-7787.
20. Groat-Carmona A.M., Orozco S., Friebe P., Payne A., Kramer L., Harris E. A novel coding-region RNA element modulates infectious dengue virus particle production in both mammalian and mosquito cells and regulates viral replication in Aedes aegypti mosquitoes. Virology 2012, 432(2):511-526.
21. Gualano R.C., Pryor M.J., Cauchi M.R., Wright P.J., Davidson A.D. Identification of a major determinant of mouse neurovirulence of dengue virus type 2 using stably cloned genomic-length cDNA. The Journal of General Virology 1998, 79(Pt 3):437-446.
22. Guzman M.G., Halstead S.B., Artsob H., Buchy P., Farrar J., Gubler D.J., Hunsperger E., Kroeger A., Margolis H.S., Martinez E., Nathan M.B., Pelegrino J.L., Simmons C., Yoksan S., Peeling R.W. Dengue: a continuing global threat. Nature Reviews Microbiology 2010, 8(12 Suppl):S7-S16.
23. Henchal E.A., Gentry M.K., McCown J.M., Brandt W.E. Dengue virus-specific and flavivirus group determinants identified with monoclonal antibodies by indirect immunofluorescence. The American Journal of Tropical Medicine and Hygiene 1982, 31(4):830-836.
24. Hsieh S.C., Zou G., Tsai W.Y., Qing M., Chang G.J., Shi P.Y., Wang W.K. The C-terminal helical domain of dengue virus precursor membrane protein is involved in virus assembly and entry. Virology 2011, 410(1):170-180.
25. Hsu Y.C., Chen N.C., Chen P.C., Wang C.C., Cheng W.C., Wu H.N. Identification of a small-molecule inhibitor of dengue virus using a replicon system. Archives of Virology 2012, 157(4):681-688.
26. Huang C.Y., Butrapet S., Tsuchiya K.R., Bhamarapravati N., Gubler D.J., Kinney R.M. Dengue 2 PDK-53 virus as a chimeric carrier for tetravalent dengue vaccine development. Journal of Virology 2003, 77(21):11436-11447.
27. Iglesias N.G., Filomatori C.V., Gamarnik A.V. The F1 motif of dengue virus polymerase NS5 is involved in promoter-dependent RNA synthesis. Journal of Virology 2011, 85(12):5745-5756.
28. Kelly E.P., Polo S., Sun W., Falgout B. Evolution of attenuating mutations in dengue-2 strain S16803 PDK50 vaccine and comparison of growth kinetics with parent virus. Virus Genes 2011, 43(1):18-26.
29. Kelly E.P., Puri B., Sun W., Falgout B. Identification of mutations in a candidate dengue 4 vaccine strain 341750 PDK20 and construction of a full-length cDNA clone of the PDK20 vaccine candidate. Vaccine 2010, 28(17):3030-3037.
30. Kim U.J., Birren B.W., Slepak T., Mancino V., Boysen C., Kang H.L., Simon M.I., Shizuya H. Construction and characterization of a human bacterial artificial chromosome library. Genomics 1996, 34(2):213-218.
31. Kinney R.M., Butrapet S., Chang G.J., Tsuchiya K.R., Roehrig J.T., Bhamarapravati N., Gubler D.J. Construction of infectious cDNA clones for dengue 2 virus: strain 16681 and its attenuated vaccine derivative, strain PDK-53. Virology 1997, 230(2):300-308.
32. Lai C.J., Zhao B.T., Hori H., Bray M. Infectious RNA transcribed from stably cloned full-length cDNA of dengue type 4 virus. Proceedings of the National Academy of Sciences of the United States of America 1991, 88(12):5139-5143.
33. Lai M.M. The making of infectious viral RNA: no size limit in sight. Proceedings of the National Academy of Sciences of the United States of America 2000, 97(10):5025-5027.
34. Leardkamolkarn V., Sirigulpanit W. Establishment of a stable cell line coexpressing dengue virus-2 and green fluorescent protein for screening of antiviral compounds. Journal of Biomolecular Screening 2012, 17(3):283-292.
35. Leardkamolkarn V., Sirigulpanit W., Chotiwan N., Kumkate S., Huang C.Y. Development of Dengue type-2 virus replicons expressing GFP reporter gene in study of viral RNA replication. Virus Research 2012, 163(2):552-562.
36. Lee T.C., Lin Y.L., Liao J.T., Su C.M., Lin C.C., Lin W.P., Liao C.L. Utilizing liver-specific microRNA-122 to modulate replication of dengue virus replicon. Biochemical and Biophysical Research Communications 2010, 396(3):596-601.
37. Lindenbach D.B., Thiel H.-J., Rice C.M. Flaviviridae: the viruses and their replication. Fields Virology 2007, 1101-1152. Wolkers Kluwer/Lippincott Williams and Wilkins, Philadelphia, PA. fifth ed. D.M. Knipe, P.M. Howley (Eds.).
38. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25(4):402-408.
39. Lodeiro M.F., Filomatori C.V., Gamarnik A.V. Structural and functional studies of the promoter element for dengue virus RNA replication. Journal of Virology 2009, 83(2):993-1008.
40. Martinez-Gutierrez M., Castellanos J.E., Gallego-Gomez J.C. Statins reduce dengue virus production via decreased virion assembly. Intervirology 2011, 54(4):202-216.
41. Modis Y., Ogata S., Clements D., Harrison S.C. Structure of the dengue virus envelope protein after membrane fusion. Nature 2004, 427(6972):313-319.
42. Munoz-Jordan J.L., Laurent-Rolle M., Ashour J., Martinez-Sobrido L., Ashok M., Lipkin W.I., Garcia-Sastre A. Inhibition of alpha/beta interferon signaling by the NS4B protein of flaviviruses. Journal of Virology 2005, 79(13):8004-8013.
43. Munoz-Jordan J.L., Sanchez-Burgos G.G., Laurent-Rolle M., Garcia-Sastre A. Inhibition of interferon signaling by dengue virus. Proceedings of the National Academy of Sciences of the United States of America 2003, 100(24):14333-14338.
44. Murray C.L., Jones C.T., Rice C.M. Architects of assembly: roles of Flaviviridae non-structural proteins in virion morphogenesis. Nature reviews: Microbiology 2008, 6(9):699-708.
45. Ng C.Y., Gu F., Phong W.Y., Chen Y.L., Lim S.P., Davidson A., Vasudevan S.G. Construction and characterization of a stable subgenomic dengue virus type 2 replicon system for antiviral compound and siRNA testing. Antiviral Research 2007, 76(3):222-231.
46. Pang X., Zhang M., Dayton A.I. Development of dengue virus replicons expressing HIV-1 gp120 and other heterologous genes: a potential future tool for dual vaccination against dengue virus and HIV. BMC Microbiology 2001, 1:28.
47. Pang X., Zhang M., Dayton A.I. Development of dengue virus type 2 replicons capable of prolonged expression in host cells. BMC Microbiology 2001, 1:18.
48. Paranjape S.M., Harris E. Control of dengue virus translation and replication. Current Topics in Microbiology and Immunology 2010, 338:15-34.
49. Pierro D.J., Salazar M.I., Beaty B.J., Olson K.E. Infectious clone construction of dengue virus type 2, strain Jamaican 1409, and characterization of a conditional E6 mutation. The Journal of General Virology 2006, 87(Pt 8):2263-2268.
50. Polo S., Ketner G., Levis R., Falgout B. Infectious RNA transcripts from full-length dengue virus type 2 cDNA clones made in yeast. Journal of Virology 1997, 71(7):5366-5374.
51. Pu S.Y., Wu R.H., Yang C.C., Jao T.M., Tsai M.H., Wang J.C., Lin H.M., Chao Y.S., Yueh A. Successful propagation of flavivirus infectious cDNAs by a novel method to reduce the cryptic bacterial promoter activity of virus genomes. Journal of Virology 2011, 85(6):2927-2941.
52. Puri B., Polo S., Hayes C.G., Falgout B. Construction of a full length infectious clone for dengue-1 virus Western Pacific, 74 strain. Virus Genes 2000, 20(1):57-63.
53. Qing M., Liu W., Yuan Z., Gu F., Shi P.Y. A high-throughput assay using dengue-1 virus-like particles for drug discovery. Antiviral Research 2010, 86(2):163-171.
54. Schoggins J.W., Dorner M., Feulner M., Imanaka N., Murphy M.Y., Ploss A., Rice C.M. Dengue reporter viruses reveal viral dynamics in interferon receptor-deficient mice and sensitivity to interferon effectors in vitro. Proceedings of the National Academy of Sciences of the United States of America 2012, 109(36):14610-14615.
55. Shizuya H., Birren B., Kim U.J., Mancino V., Slepak T., Tachiiri Y., Simon M. Cloning and stable maintenance of 300-kilobase-pair fragments of human DNA in Escherichia coli using an F-factor-based vector. Proceedings of the National Academy of Sciences of the United States of America 1992, 89(18):8794-8797.
56. Sriburi R., Keelapang P., Duangchinda T., Pruksakorn S., Maneekarn N., Malasit P., Sittisombut N. Construction of infectious dengue 2 virus cDNA clones using high copy number plasmid. Journal of Virological Methods 2001, 92(1):71-82.
57. St-Jean J.R., Desforges M., Almazan F., Jacomy H., Enjuanes L., Talbot P.J. Recovery of a neurovirulent human coronavirus OC43 from an infectious cDNA clone. Journal of Virology 2006, 80(7):3670-3674.
58. Suzuki R., de Borba L., Duarte dos Santos C.N., Mason P.W. Construction of an infectious cDNA clone for a Brazilian prototype strain of dengue virus type 1: characterization of a temperature-sensitive mutation in NS1. Virology 2007, 362(2):374-383.
59. TDR/WHO Dengue Guidelines for Diagnosis, Treatment, Prevention and Control 2009, World Health Organization, Geneva, Switzerland.
60. Yu L., Nomaguchi M., Padmanabhan R., Markoff L. Specific requirements for elements of the 5″ and 3' terminal regions in flavivirus RNA synthesis and viral replication. Virology 2008, 374(1):170-185.
61. Zhu W., Qin C., Chen S., Jiang T., Yu M., Yu X., Qin E. Attenuated dengue 2 viruses with deletions in capsid protein derived from an infectious full-length cDNA clone. Virus Research 2007, 126(1-2):226-232.
62. Zou G., Xu H.Y., Qing M., Wang Q.Y., Shi P.Y. Development and characterization of a stable luciferase dengue virus for high-throughput screening. Antiviral Research 2011, 91(1):11-19.